What does Agenus, Inc. do?

Jun 22 2025 06:14 PM IST
share
Share Via
Agenus, Inc. is an immuno-oncology company developing therapies to harness the immune system against cancer, with a market cap of $131.05 million and recent net sales of $24 million. The company reported a net loss of $26 million for the quarter ending March 2025.
Overview:
Agenus, Inc. is an immuno-oncology company focused on developing therapies that engage the body's immune system to combat cancer, operating within the Pharmaceuticals & Biotechnology industry and classified as a micro-cap company.

Financial Snapshot:
Most recent Net Sales: 24 Million (Quarterly Results - Mar 2025)
Most recent Net Profit: -26 Million (Quarterly Results - Mar 2025)
Market-cap: USD 131.05 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -1.01
Return on Equity: 57.81%
Price to Book: -0.38

Contact Details:
Address: 3 Forbes Rd, LEXINGTON MA: 02421-7305
Tel: 1 781 6744400
Fax: 1 781 6744200
Website: http://agenusbio.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Agenus, Inc. technically bullish or bearish?
Sep 20 2025 07:17 PM IST
share
Share Via
Is Agenus, Inc. overvalued or undervalued?
Sep 20 2025 05:52 PM IST
share
Share Via
Is Agenus, Inc. overvalued or undervalued?
Jun 25 2025 08:28 AM IST
share
Share Via
Is Agenus, Inc. technically bullish or bearish?
Jun 25 2025 08:25 AM IST
share
Share Via
Who are in the management team of Agenus, Inc.?
Jun 22 2025 10:12 PM IST
share
Share Via
How big is Agenus, Inc.?
Jun 22 2025 05:41 PM IST
share
Share Via